TrialSignal
Clinical trial intelligence report
Evaluation of the Venous Thrombotic Biological Profile of Different PCOS Phenotypes: French Cross-sectional Study
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT06339567-Jul 28, 2026
NCT ID
NCT06339567
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Sponsor
Fondation Hôpital Saint-Joseph
Executive brief
Investment-Ready Snapshot
The study, sponsored by Fondation Hôpital Saint-Joseph, aims to evaluate the venous thrombotic biological profile across various PCOS phenotypes, addressing a significant gap in understanding the cardiovascular risks associated with PCOS. With PCOS being the most prevalent endocrine disorder among women of childbearing age, the findings could lead to improved clinical management and personalized treatment strategies, potentially enhancing the market for diagnostic tests and therapeutic interventions targeting PCOS. The competitive landscape may include other diagnostic and therapeutic entities focused on PCOS and related cardiovascular risks, necessitating thorough diligence to identify potential partnerships or acquisition targets.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT06339567
Indication
Polycystic Ovary Syndrome
Modality
protein therapy
Target
Thrombotic biological markers related to venous thromboembolism (VTE) risk in women with different phenotypes of Polycystic Ovary Syndrome (PCOS).
Intervention
Thrombotic profile
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.